4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-23-003741
President and CEO acquired 114,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph President and CEO | 2023-01-17 | Grant or award | +114,000 | 116,685 | D | ||
| Derivatives | |||||||
| OConnell Daniel Joseph President and CEO | 2023-01-17 | Grant or award · Employee Stock Option (right to buy) | +472,500 | 472,500 | D | ||
Loading xslF345X03/doc4.xml…